Resultados de Búsqueda
It is recommended to follow R&D protocols to ensure vaccine safety.
Evidencias COVID-19
Cochrane Portugal - Institute for Evidenced Based Health
The safety profile of the most common vaccines is excellent, with clinically insignificant side effects. Pharmacovigilance systems have proven crucial to have an accurate idea of risk. To ensure the safety of SARS-CoV-2 vaccines, R&D methodologies must follow the usual steps.
ver más ... 2020It is not recommended the use of antimalarials in patients hospitalized for COVID-19
Evidencias COVID-19
Fundación Cardioinfantil - Cochrane Colombia
There is no certainty about the relationship between treatment-induced viral clearance and its effect on clinical outcomes. The clinical impact of antimalarial treatment is uncertain. Indeed, an interim analysis in a large RCT, recommending continued randomization to this treatment, showed a statistically different effect from the excess risk identified by a large observational study.
ver más ... 2020Preventive or mitigation psychological strategies are recommended in health workers involved in the control of emerging virus outbreaks, since they are at greater risk of presenting psychological ...
Evidencias COVID-19
Centro Cochrane Iberoamericano
Based on studies of previous outbreaks, individual, organizational and social factors were identified that favored or reduced the risk of psychological impact. Risk factors for psychological impact can be addressed with preventive or mitigation strategies applied in previous outbreaks of emerging viruses.
ver más ... 2020The measures of containment (confinement, isolation of infected persons, social distancing, among others) have shown a rapid and sustained impact on the reproduction rate of the SARS-CoV-2 virus and ...
Evidencias COVID-19
Centro Cochrane Iberoamericano
Two studies show the impact of public health measures to prevent the spread of the SARS-CoV-2 virus in Wuhan and Hong Kong
ver más ... 2020Ivermectin is not recommended for the treatment of SARS-CoV-2.
Evidencias COVID-19
Epistemonikos - COVID-19 L·OVE Working Group
An in vitro studio and a pair of observational studies with multiple slopes, there is a need for ivermectin, another antiparasitic. It would appear that ivermectin in junction is hydroxychloroquine in April. Unfortunately, we are repeating history. Due to the increase in ivermectin sources, the OPS launched a warning to stop using it.
ver más ... 2020